ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CMBN Cambian Group

192.40
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cambian Group LSE:CMBN London Ordinary Share GB00BKXNB024 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 192.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cambian Share Discussion Threads

Showing 1 to 10 of 400 messages
Chat Pages: Latest  4  3  2  1
DateSubjectAuthorDiscuss
30/4/2014
09:41
Other than 'in line with expectations', the interim statement isn't much help either!
bennytheball
29/4/2014
08:21
Sorry - not sure of the forecast.
bennytheball
29/4/2014
07:53
Hi Benny. Do you know what the Profit Before Tax forecast is for 2014? I'm not familiar with EBITDA etc. I'm not that clever!
mintitan
26/4/2014
15:11
As for debt, would like to see the exact numbers, but recall it's low for this sector as most acquisitions funded by the exiting shareholders rather than loans. My notes say £325m (?) property assets, similar total liabilities and £125m net assets.

Not clear about 2014 forecast, but the link below re Priory results suggest the market is buoyant as the dust settles after the last bout of commissioning restructuring -

PRIORY GROUP NO. 3 PLC Results for the Quarter and Year Ended 31 December 2013



"•Revenue for Q4 2013 increased by £8.2m to £124.2m, a rise of 7.1% (Q4 2012: £116.0m), predominantly due to the Healthcare division, driven by NHS Acute bed demand ...
"2013 was an important year in the Group's development. The uncertainty caused by the changes to the commissioning landscape resulted in a period of short term disruption for the Group's healthcare business but this has now dissipated and the Group is beginning to see increasing opportunities to build on our already strong relationships with commissioners..."

bennytheball
26/4/2014
11:52
Hi mintitan
Edited this having checked my numbers again.
My notes say £38m EBITDA (£44m excluding exceptionals).
With the mc now £388m, that's a more realistic x10.2 P/E (x8.9 excluding exceptionals)
But heh - glad at least I'm not talking to myself any more - that and a modest increase to 226p, I'd say it's been a good week ;-)

bennytheball
25/4/2014
21:18
This company came up on my radar so am doing some research. I understand in 2013 they made £7.8m PBT. Against their current market cap of £379m, that's a PBT to MCAP of approx 49 x. Seems rather a lot to me! Am I missing something? Are their any forecasts for PBT for 2014? And what is their net debt? I really like the sector but would like to see how the fundamentals stack up before investing. Thanks in advance.
mintitan
22/4/2014
13:28
From the RNSs so far, it looks like about 21% of the shares are in institutional hands, reducing the effective free float. (I assume they won't be selling anywhere near the IPO price of 225p.) Interesting to see what happens once the news flow starts.

F&C Asset Management PLC 15/4 8,750,000 5.08%
Polar Capital LLP 15/4 5,504,906 3.19%
BlackRock, Inc. 16/4 8,875,000 5.15%
Schroder Investment Management Ltd 22/4 12,700,000 7.369%

bennytheball
14/4/2014
09:51
The London Stock Exchange ended the volatile week by welcoming three new listings to the market: Polypipe, Exova and Cambian. Crucially, the trio were a welcome break from the glut of technology listings and a return to more traditional British companies. While industrials Exova and Polypipe saw relatively steady trading, Cambian was blasted by investors.
bennytheball
11/4/2014
11:29
Thanks 5bag.

Been playing with bank stocks and oil for a few years, but I've been keen to get back into healthcare sector since making a lot on MMG a few years back.

Cambian looks like a quality company, poised for growth in a market (learning disability, special education, mental healthcare) that should come back into favour about now after a bad time with NHS commissioning changes and negativity around Southern Cross, Winterbourne, etc. Priory have just posted improved results.

I see it's down currently from IPO price 225p, but assuming there's virtually no market yet. will be interesting to see the volume of trades as well as the share price over the coming weeks.

Have opened a long position with IG for £50/pt at 202p.

bennytheball
11/4/2014
10:50
Nice one Benny. GL. :-)
5bag
Chat Pages: Latest  4  3  2  1

Your Recent History

Delayed Upgrade Clock